ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1944 • 2019 ACR/ARP Annual Meeting

    Two Biomarkers with Predictive Capacity to Diagnosis Pre-Radiographic Knee Osteoarthritis: Data from the Osteoarthritis Initiative

    María Camacho-Encina1, Vanesa Balboa-Barreiro 2, Rocío Paz-González 3, Valentina Calamia 3, Lucía Lourido 4, Patricia Fernández-Puente 3, Cristina Ruiz-Romero 5 and Francisco J. Blanco 6, 1Proteomics Group-ProteoRed/ISCIII, Grupo de Investigación de Reumatología (GIR), INIBIC – Hospital Universitario de A Coruña, A Coruña, Spain., A Coruña, Spain, 2Grupo de Investigación de Reumatología (GIR), INIBIC-Hospital Universitario de A Coruña, A Coruña, Spain, A Coruña, Galicia, Spain, 3Proteomics Group, Rheumatology Division, ProteoRed, PRB2-ISCIII. INIBIC-Hospital Universitario A Coruña,15006 A Coruña-Spain, A Coruña, Galicia, Spain, 4Proteomics Group-ProteoRed/ISCIII, RIER, Grupo de Investigación de Reumatología (GIR), INIBIC – Hospital Universitario de A Coruña, A Coruña, Spain., A Coruña, Spain, 5Proteomics Group-ProteoRed/ISCIII, CIBER-BBN, Grupo de Investigación de Reumatología (GIR), INIBIC – Hospital Universitario de A Coruña, A Coruña, Spain., A Coruña, Spain, 6Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España, A Coruña, Spain

    Background/Purpose: Osteoarthritis (OA) is the most prevalent rheumatic disorder of the middle-age population. The lack of sensitive diagnostics methods led to an identification of the…
  • Abstract Number: 1945 • 2019 ACR/ARP Annual Meeting

    Polymorphisms in Genes Involved in Methotrexate Pathway: Predictor of Response to Methotrexate Therapy in Indian Rheumatoid Arthritis Patients

    Ankita Singh1, Harikrishnan Nair 2, Vikas Gupta 2, Pradeepta Sekhar 2, Ramnath Misra 3 and Amita Aggarwal 4, 1Sanjay Gandhi Post Graduate institute of medical science, Lucknow, India, Lucknow, Uttar Pradesh, India, 2Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, 3Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Lucknow, Uttar Pradesh, India, 4Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, Lucknow, Uttar Pradesh, India

    Background/Purpose: Methotrexate (MTX) is first line therapy to treat rheumatoid arthritis (RA) patients. However, the response is variable with 50-60% showing response and this variability…
  • Abstract Number: 1946 • 2019 ACR/ARP Annual Meeting

    Metabolic Regulation in Cybrids Obtained from Healthy and Osteoarthritic (OA) Patients: Impaired Metabolic Flexibility in OA Process

    Andrea Dalmao-Fernández1, Jenny Lund 2, Tamara Hermida-Gómez 3, María E. Vázquez-Mosquera 1, Ignacio Rego-Pérez 4, Francisco J. Blanco 4 and Mercedes Fernandez-Moreno 5, 1Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España, A Coruña, Galicia, Spain, 2Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway, 3Unidad de Bioingeniería Tisular y Terapia Celular (GBTTC-CHUAC). Grupo de Investigación en Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC). Sergas. Centro de Investigaciones Científicas Avanzadas (CICA), A Coruña, Spain, 4Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España, A Coruña, Spain, 5Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España. CIBER-BBM, A Coruña, Spain

    Background/Purpose: Background: Osteoarthritis (OA) is the most frequent joint disease.The OA is a heterogeneous disorder. With acceptance of the joint as an organ, the pathogenesis…
  • Abstract Number: 1947 • 2019 ACR/ARP Annual Meeting

    Integrating Genetic Risk Scores and Pre-Diagnostic Metabolomics to Infer Dysregulated Mechanisms in Rheumatoid Arthritis in Women

    Su H. Chu1, Jing Cui 2, Jeffrey Sparks 2, Bing Lu 2, Clary Clish 3, Jessica Lasky-Su 1, Elizabeth Karlson 2 and Karen Costenbader 2, 1Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Broad Institute of MIT and Harvard, Boston, MA

    Background/Purpose: Rheumatoid arthritis genetic risk scores (RA-GRS) improve RA risk prediction, but the added predictive value over lifestyle risk factors is modest. Several human leukocyte…
  • Abstract Number: 1948 • 2019 ACR/ARP Annual Meeting

    The Mechanism of DC-STAMP-Mediated Signaling in Cell-Cell Fusion and Osteoclast Maturation

    Ananta Paine1, Kerstin Tiedemann 2, Maria de la luz Garcia-Hernandez 1, Svetlana Komarova 2 and Christopher Ritchlin 1, 1Division of Allergy, Immunology and Rheumatology, Center for Musculoskeletal Research, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA, Rochester, NY, 2Faculty of Dentistry, McGill University, Montreal, Quebec, Canada; Shriners Hospital for Children-Canada, Montreal, Quebec, Canada, Montréal, QC, Canada

    Background/Purpose: Osteoclasts (OC) are bone-resorbing, multinuclear cells that originate from myeloid progenitor cells through repetitive cycles of cell-cell fusion. Dendritic cell-specific transmembrane protein (DC-STAMP) is…
  • Abstract Number: 1949 • 2019 ACR/ARP Annual Meeting

    The p.R321C Mutation in P62 Associated with Paget’s Disease of Bone Leads to a Change of Localization of the Protein in Human Osteoclasts

    Nerea Gestoso-Uzal 1, Ricardo Usategui-Martín 1, Rogelio González-Sarmiento 1 and Javier Del Pino-Montes1, 1Salamanca Institute of Biomedical Research (IBSAL), University Hospital of Salamanca- University of Salamanca, Salamanca-CSIC, Spain, Salamanca, Castilla y Leon, Spain

    Background/Purpose: Paget´s disease of bone (PDB) is a chronic bone metabolic disorder. Currently, PDB is a focal disorder characterized by an increase in bone turnover…
  • Abstract Number: 1950 • 2019 ACR/ARP Annual Meeting

    Apolipoprotein L1 Variant-Carrying Monocytes Exhibit Mitochondrial Respiration Defects

    Ashira Blazer1, Miao Chang 1, Kimberly Robins 1, Jill Buyon 2 and Robert Clancy 2, 1NYU School of Medicine, New York, NY, 2NYU School of Medicine, New York

    Background/Purpose: In SLE Apolipoprotein L1 (APOL1) risk variants associate with cardiovascular and kidney damage. APOL1 is both a secreted and tissue intrinsic protein; the latter…
  • Abstract Number: 1951 • 2019 ACR/ARP Annual Meeting

    Transcriptomic Responses in CD4+ T Cells During Successful Therapy for Juvenile Idiopathic Arthritis

    Tarbell Evan 1, Kaiyu Jiang 1, Tao Liu 2 and James N. Jarvis3, 1University at Buffalo Jacobs School of Medicine, Buffalo, NY, 2Roswell Park Cancer Instiyute, Buffalo, NY, 3University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY

    Background/Purpose: We have shown that therapeutic response in juvenile idiopathic arthritis (JIA) is a non-linear process invloving reorganization of gene expression networks. However, our earlier…
  • Abstract Number: 1952 • 2019 ACR/ARP Annual Meeting

    Genes Associated with Nucleotide Oligomerization Domain-Like Receptor Signaling Pathway Are Upregulated in Discoid Lupus Erythematosus

    Irene Calderon1, Inhan Lee 2 and Rina Mina 3, 1SCDS, Cincinnati, OH, 2mcore, Ann Arbor, MI, 3University of Cincinnati, Cincinnati

    Background/Purpose: Background: Discoid Lupus Erythematosus (DLE) is disfiguring autoimmune skin disorder, associated with defects in the adaptive immune system. The innate immune system is likely…
  • Abstract Number: 1953 • 2019 ACR/ARP Annual Meeting

    Estimating the Infiltration of Immune Cells in Synovium of Rheumatoid Arthritis Compared to Osteoarthritis and Healthy Control Using Transcriptomic Profiling

    Mahmood Hachim1, Noha Elemam 1, Ibrahim Hachim 2, Suad Hannawi 3, Rifat Hamoudi 4 and Azzam Maghazachi 1, 1Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah, Sharjah, United Arab Emirates, 2Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates, 3Ministry of Health and Prevention, Department of Rheumatology, Dubai, United Arab Emirates, 41Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates

    Background/Purpose: Rheumatoid arthritis (RA) is one of the most prevalent autoimmune and prototypic inflammatory diseases. It is a heterogeneous autoimmune disease with local and systemic…
  • Abstract Number: 1954 • 2019 ACR/ARP Annual Meeting

    Association of Functional (GA)n Microsatellite Polymorphism in the FLI1 Gene with Susceptibility to Human Systemic Sclerosis

    Aya Kawasaki1, Keita Yamashita 2, Takashi Matsushita 3, Hiroshi Furukawa 4, Yuya Kondo 5, Naoko Okiyama 6, Shouhei Nagaoka 7, Kota Shimada 8, Shoji Sugii 9, Masao Katayama 10, Shunsei Hirohata 11, Akira Okamoto 12, Noriyuki Chiba 13, Eiichi Suematsu 14, Keigo Setoguchi 15, Kiyoshi Migita 16, Takayuki Sumida 5, Shigeto Tohma 17, Minoru Hasegawa 18, Yasuhito Hamaguchi 3, Shinichi Sato 19, Yasushi Kawaguchi 20, Kazuhiko Takehara 3 and Naoyuki Tsuchiya 1, 1Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 2Doctoral Program in Biomedical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan, 3Department of Dermatology, Kanazawa University, Kanazawa, Japan, 4Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan, 5Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 6Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 7Yokohama Minami Kyousai Hospital, Yokohama, Kanagawa, Japan, 8Department of Rheumatic Diseases, Tokyo Metropoitan Tama Medica Center, Fuchu, 9Department of Rheumatic Diseases, Tokyo Metropoitan Tama Medica Center, Fuchu, Japan, 10National Hospital Organization Nagoya Medical Center, Nagoya, Japan, 11Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Tatsuno, Japan, 12National Hospital Organization HImeji Medical Center, Himeji, Hyogo, Japan, 13National Hospital Organization Morioka Medical Center, Morioka, Iwate, Japan, 14National Hospital Organization Kyushu Medical Center, Fukuoka, Japan, 15Tokyo Metropolitan Cancer and Infectious Dease Center Komagome Hospital, Tokyo, Tokyo, Japan, 16Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan, 17National Hospital Organization Tokyo National Hospital, Kiyose, Japan, 18Department of Dermatology, Fukui University, Fukui, 19University of Tokyo Graduate School of Medicine, Department of Dermatology, Tokyo, Japan, 20Department of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan

    Background/Purpose: Susceptibility genes which can account for the characteristic features of systemic sclerosis (SSc) such as fibrosis, vasculopathy and autoimmunity remain to be determined. A…
  • Abstract Number: 1955 • 2019 ACR/ARP Annual Meeting

    Association of TERT and DSP Polymorphisms with Susceptibility to Myeloperoxidase-ANCA-Associated Vasculitis

    Aya Kawasaki1, Natsumi Namba 1, Ken-ei Sada 2, Fumio Hirano 3, Shigeto Kobayashi 4, Hidehiro Yamada 5, Hiroshi Furukawa 6, Kenji Nagasaka 7, Takahiko Sugihara 8, Aika Suzuki 9, Kunihiro Yamagata 10, Takayuki Sumida 11, Shigeto Tohma 12, Sakae Homma 13, Shoichi Ozaki 14, Hiroshi Hashimoto 15, Hirofumi Makino 16, Yoshihiro Arimura 17, Masayoshi Harigai 18 and Naoyuki Tsuchiya 1, 1Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 2Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Kitaku, Okayama, Japan, 3Department of Rheumatology, Tokyo Medical and Dental University, Tokyo, Japan, 4Department of Internal Medicine, Juntendo University Koshigaya Hospital, Koshigaya, Japan, 5Center for Rheumatic diseases, Seirei Yokohama Hospital, Kawasaki, Japan, 6Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan, 7Department of Rheumatology, Ome Municipal General Hospital, Tokyo, 8Department of Lifetime Clinical Immunology, Tokyo Medical and Dental University, Tokyo, Japan, 9Department of Respiratory Medicine, Toho University Graduate School of Medicine, Tokyo, Japan, 10Department of Nephrology, University of Tsukuba, Tsukuba, Ibaraki, Japan, 11Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 12National Hospital Organization Tokyo National Hospital, Kiyose, Japan, 13Department of Advanced and Integrated Interstitial Lung Diseases Research, School of Medicine, Toho University, Tokyo, Japan, 14St. Marianna University School of Medicine, Kawasaki, Japan, 15Juntendo University School of Medicine, Tokyo, Japan, 16Okayama University, Okayama, Japan, 17Nephrology and Rheumatology, Kyorin University School of Medicine, Tokyo, Japan, 18Department of Rheumatology, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Tokyo, Japan

    Background/Purpose: Epidemiology of ANCA-associated vasculitis (AAV) is substantially different between East Asian and European populations. Microscopic polyangiitis (MPA) and MPO-ANCA positive AAV (MPO-AAV) are prevalent…
  • Abstract Number: 1956 • 2019 ACR/ARP Annual Meeting

    Characterizing Arthritis Related to Immune Checkpoint Inhibitors Using Synovial Fluid and Matched Blood

    Mazen Nasrallah1, Molly Thomas 2, Kasidet Manakongtreecheep 2, Daniel Zlotoff 2, Aleigha Lawless 2, Hellen Giang 2, Sara Schoenfeld 2, Ryan Sullivan 2, Genevieve Boland 2, Kerry Reynolds 2, Minna Kohler 2, Andrew Luster 2 and Alexandra-Chloé Villani 2, 1Massachusetts General Hospital, Boston, 2MGH, Boston

    Background/Purpose: Monoclonal antibodies against CTLA-4 and PD-1 have revolutionized the field of immuno-oncology over the past decade. These therapies however are limited by immune related…
  • Abstract Number: 1957 • 2019 ACR/ARP Annual Meeting

    Aggregation of Functional Variants in NOTCH4 Gene Increases SSc Risk

    Pravitt Gourh1, Sarah Safran 2, Theresa Alexander 3, Steven Boyden 4, Ami Shah 5, Maureen Mayes 6, Ayo Doumatey 7, Amy Bentley 7, Daniel Shriner 7, Robyn Domsic 8, Thomas Medsger Jr 9, Paula Ramos 10, Richard Silver 11, Virginia Steen 12, John Varga 13, Vivien Hsu 14, Lesley Saketkoo 15, Elena Schiopu 16, Dinesh Khanna 17, Jessica Gordon 18, Brynn Kron 19, Lindsey Criswell 20, Heather Gladue 21, Chris Derk 22, Elana Bernstein 23, S Louis Bridges 24, Victoria Shanmugam 25, Kathleen Kolstad 26, Lorinda Chung 27, Suzanne Kafaja 28, Reem Jan 29, Marcin Trojanowski 30, Avram Goldberg 31, Benjamin Korman 32, Peter Steinbach 33, Settara Chandrasekharappa 7, James Mullikin 7, Adebowale Adeyemo 7, Charles Rotimi 7, Frederick Wigley 34, Daniel Kastner 35, Francesco Boin 36 and Elaine Remmers 7, 1National Institutes of Rheumatology, Bethesda, 2National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, MD, 3University of Maryland, College Park, MD, 4University of Utah, SALT LAKE CITY, UT, 5Johns Hopkins Hospital, Baltimore, MD, 6Division of Rheumatology and Clinical Immunogenetics, University of Texas McGovern Medical School, Houston, Texas, USA, Houston, TX, 7National Human Genome Research Institute (NHGRI), Bethesda, MD, 8University of Pittsburgh, Pittsburgh, PA, 9University of Pittsburg School of Medicine, Pittsburg, PA, 10Medical University of South Carolina, Charleston, 11Division of Rheumatology, Medical University of South Carolina, Charleston, SC, 12Georgetown University, Washington, D.C., USA, Georgetown, 13Northwestern University, Chicago,, IL, 14Rutgers- RWJ Medical School, SOUTH PLAINFIELD, NJ, 15New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans; Tulane University School of Medicine, University Medical Center – Comprehensive Pulmonary Hypertension Center, USA, New Orleans, 16Department of Rheumatology, University of Michigan, Ann Arbor, 17Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA, Ann Arbor, 18Hospital for Special Surgery, New York, NY, 19University of California San Francisco, San Francisco, CA, 20University of California, San Francisco, San Francisco, 21Arthritis & Osteoporosis Consultants Of The Carolinas, Charlotte, NC, 22University of Pennsylvania, Philadelphia, PA, 23Division of Rheumatology, Columbia University, New York, NY, 24University of Alabama at Birmingham, Birmingham, 25George Washington University, Georgetown, DC, 26Division of Immunology and Rheumatology, Department of Medicine, Stanford University, Stanford, CA, 27Stanford University, Palo Alto, CA, 28Department of Medicine. Rheumatology Division. UCLA, Los Angeles, CA, 29University of Chicago Pritzker School of Medicine, Chicago, IL, 30Boston University Medical Center, Boston, MA, 31New York University Langone Medical Center, New York, NY, 32University of Rochester Medical Center, Rochester, NY, 33Center for Molecular Modeling, Center for Information Technology, National Institutes of Health, Bethesda, MD, 34Johns Hopkins University, Division of Rheumatology, Baltimore, 35National Institutes of Health, Bethesda, MD, 36UCSF, San Francisco, CA

    Background/Purpose: Genetic studies of common variants in scleroderma (systemic sclerosis, SSc) have identified several susceptibility loci increasing SSc risk. Most of these common variants are…
  • Abstract Number: 1958 • 2019 ACR/ARP Annual Meeting

    Contribution of MOCS on Xanthinuria Type III and Its Clinical Significance for Screening

    Sung Kweon Cho1 and Blanka Stiburkova 2, 1NCI, Frederick, MD, 2Institute of Rheumatology; Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic, Prague, Czech Republic

    Background/Purpose: Xanthinuria is a rare inherited disorder of purine metabolism (1 in 69,000). In the first step, determination of serum and urinary uric acid and…
  • « Previous Page
  • 1
  • …
  • 886
  • 887
  • 888
  • 889
  • 890
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology